Impact of Plan-Level Access Restrictions on Effectiveness of Biologics Among Patients With Rheumatoid or Psoriatic Arthritis
PharmacoEconomics - Open - Switzerland
doi 10.1007/s41669-019-0152-1
Full Text
Open PDFAbstract
Available in full text
Date
June 8, 2019
Authors
Publisher
Springer Science and Business Media LLC